Comparing ovarian stimulation methods for IVF
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 to 40 years.
- You must be undergoing in vitro fertilization (IVF) treatment.
- Your body mass index (BMI) must be 35 or lower.
- You must not have ovarian endometriomas or a history of severe ovarian hyperstimulation syndrome.
- You must not have severe hormonal disorders, cancer, or other conditions that prevent hormonal stimulation.
- You must not have male factor infertility due to cryptozoospermia (very low sperm count).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of giving fertility medication to stimulate the ovaries before retrieving eggs for IVF (in vitro fertilization). One method starts after ovulation and uses a drug called Elonva without a routine blocking medication, while the other is the standard approach starting early in the cycle. The goal is to see which approach leads to better outcomes for people undergoing IVF or ICSI (a procedure where a single sperm is injected into an egg).
This trial compares two different ways of stimulating the ovaries in women who have a poor response to fertility treatment. It aims to see which method gives a higher chance of having a live baby.
This trial compares two different 'trigger shots' — a final medication that helps your eggs mature before they are collected. It is for women with a normal egg supply who are doing IVF with ICSI. Taking part may help your doctor learn which trigger works better for your situation, potentially leading to more mature eggs and better chances of success.
This study compares two common IVF stimulation protocols (progestin-primed vs. antagonist) to see which works better for women who produce many eggs. If you are a 'high responder,' this trial may help find the best approach for you.
This trial tests two different medications to trigger ovulation before egg retrieval in women with a normal response to IVF. It compares a single standard trigger with a modified dual trigger approach to see which works better.
This trial tests whether giving the hormone that triggers ovulation in two doses is better than one dose for people who over-respond to fertility treatment. It is designed for those having in vitro fertilization (IVF) with a GnRH antagonist protocol.
Hear when a new Infertility (IVF Patients) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.